<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="correction"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Bioeng Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">Front Bioeng Biotechnol</journal-id><journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id><journal-title-group><journal-title>Frontiers in Bioengineering and Biotechnology</journal-title></journal-title-group><issn pub-type="epub">2296-4185</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40400777</article-id><article-id pub-id-type="pmc">PMC12093324</article-id><article-id pub-id-type="publisher-id">1601751</article-id><article-id pub-id-type="doi">10.3389/fbioe.2025.1601751</article-id><article-categories><subj-group subj-group-type="heading"><subject>Bioengineering and Biotechnology</subject><subj-group><subject>Correction</subject></subj-group></subj-group></article-categories><title-group><article-title>Corrigendum: Therapeutic effects of zoledronic acid-loaded hyaluronic acid/polyethylene glycol/nano-hydroxyapatite nanoparticles on osteosarcoma</article-title><alt-title alt-title-type="left-running-head">Xu et al.</alt-title><alt-title alt-title-type="right-running-head">
<ext-link xlink:href="https://doi.org/10.3389/fbioe.2025.1601751" ext-link-type="uri">10.3389/fbioe.2025.1601751</ext-link>
</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Xu</surname><given-names>Yan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1007701/overview"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/methodology/"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Qi</surname><given-names>Jingqi</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn001" ref-type="author-notes">
<sup>&#x02020;</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1749909/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Wei</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/1750655/overview"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/></contrib><contrib contrib-type="author"><name><surname>Zhong</surname><given-names>Wu</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wu</surname><given-names>Hongwei</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">*</xref><uri xlink:href="https://loop.frontiersin.org/people/1143683/overview"/><role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x00026; editing/"/><role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/></contrib></contrib-group><aff id="aff1">
<sup>1</sup>
<institution>Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine</institution>, <institution>Central South University</institution>, <addr-line>Changsha</addr-line>, <country>China</country>
</aff><aff id="aff2">
<sup>2</sup>
<institution>Zhejiang University-University of Edinburgh Institute</institution>, <addr-line>Haining</addr-line>, <country>China</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited and reviewed by:</bold>
<ext-link xlink:href="https://loop.frontiersin.org/people/489389/overview" ext-link-type="uri">Jianxun Ding</ext-link>, Chinese Academy of Sciences (CAS), China</p></fn><corresp id="c001">*Correspondence: Hongwei Wu, <email>wuhongwei@hnca.org.cn</email>
</corresp><fn fn-type="equal" id="fn001"><label>
<sup>&#x02020;</sup>
</label><p>These authors have contributed equally to this work</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>07</day><month>5</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>13</volume><elocation-id>1601751</elocation-id><history><date date-type="received"><day>28</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>24</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Xu, Qi, Sun, Zhong and Wu.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Xu, Qi, Sun, Zhong and Wu</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><related-article related-article-type="corrected-article" ext-link-type="doi" id="RA1" xlink:href="10.3389/fbioe.2022.897641" journal-id="Front. Bioeng. Biotechnol." journal-id-type="nlm-ta">A Corrigendum on <article-title>Therapeutic effects of zoledronic acid-loaded hyaluronic acid/polyethylene glycol/nano-hydroxyapatite nanoparticles on osteosarcoma</article-title> by Xu Y, Qi J, Sun W, Zhong W and Wu H (2022). Front. Bioeng. Biotechnol. 10:897641. doi: <object-id>10.3389/fbioe.2022.897641</object-id>
</related-article><kwd-group><kwd>nanoparticle</kwd><kwd>osteosarcoma</kwd><kwd>zoledronic acid</kwd><kwd>tumor therapy</kwd><kwd>targeted therapy</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Biomaterials</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>In the published article, there was an error in <xref rid="F2" ref-type="fig">Figure 2</xref> as published. In <xref rid="F2" ref-type="fig">Figures 2C, D</xref>, an image was mistakenly duplicated. The corrected <xref rid="F2" ref-type="fig">Figure 2</xref> and its caption appear below.</p><fig position="float" id="F2"><label>FIGURE 2</label><caption><p>Effect of nanoparticles on three types of normal cells and three osteosarcoma cell lines. <bold>(A)</bold> Photoscopic images of three normal cell types (HSFs, ASCs, and BMSCs) treated with 0&#x02013;50&#x000a0;&#x003bc;g/mL concentrations of nanoparticles. <bold>(B)</bold> Relative cell viability of three normal cell lines under 0&#x02013;50&#x000a0;&#x003bc;g/mL concentrations of nanoparticles. <bold>(C, E)</bold> Photoscopic images and relative cell viability of three kinds of osteosarcoma cells (143b, HOS, and MG63) treated with 0&#x02013;10&#x000a0;&#x003bc;g/mL concentrations of nanoparticles. <bold>(D, F)</bold> Photoscopic images and relative cell viability of 143b cells treated with 0&#x02013;1&#x000a0;&#x003bc;g/mL concentrations of nanoparticles. Scale bar = 100&#x000a0;um.&#x0201d;</p></caption><graphic xlink:href="fbioe-13-1601751-g002" position="float"/></fig><p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p></body><back><sec sec-type="disclaimer" id="s1"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec></back></article>